Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype - PubMed (original) (raw)
Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype
A Björndal et al. J Virol. 1997 Oct.
Abstract
The biological phenotype of primary human immunodeficiency virus type 1 (HIV-1) isolates varies according to the severity of the HIV infection. Here we show that the two previously described groups of rapid/high, syncytium-inducing (SI) and slow/low, non-syncytium-inducing (NSI) isolates are distinguished by their ability to utilize different chemokine receptors for entry into target cells. Recent studies have identified the C-X-C chemokine receptor CXCR4 (also named fusin or Lestr) and the C-C chemokine receptor CCR5 as the principal entry cofactors for T-cell-line-tropic and non-T-cell-line-tropic HIV-1, respectively. Using U87.CD4 glioma cell lines, stably expressing the chemokine receptor CCR1, CCR2b, CCR3, CCR5, or CXCR4, we have tested chemokine receptor specificity for a panel of genetically diverse envelope glycoprotein genes cloned from primary HIV-1 isolates and have found that receptor usage was closely associated with the biological phenotype of the virus isolate but not the genetic subtype. We have also analyzed a panel of 36 well-characterized primary HIV-1 isolates for syncytium induction and replication in the same series of cell lines. Infection by slow/low viruses was restricted to cells expressing CCR5, whereas rapid/high viruses could use a variety of chemokine receptors. In addition to the regular use of CXCR4, many rapid/high viruses used CCR5 and some also used CCR3 and CCR2b. Progressive HIV-1 infection is characterized by the emergence of viruses resistant to inhibition by beta-chemokines, which corresponded to changes in coreceptor usage. The broadening of the host range may even enable the use of uncharacterized coreceptors, in that two isolates from immunodeficient patients infected the parental U87.CD4 cell line lacking any engineered coreceptor. Two primary isolates with multiple coreceptor usage were shown to consist of mixed populations, one with a narrow host range using CCR5 only and the other with a broad host range using CCR3, CCR5, or CXCR4, similar to the original population. The results show that all 36 primary HIV-1 isolates induce syncytia, provided that target cells carry the particular coreceptor required by the virus.
Similar articles
- Chemokine coreceptor usage by diverse primary isolates of human immunodeficiency virus type 1.
Zhang L, He T, Huang Y, Chen Z, Guo Y, Wu S, Kunstman KJ, Brown RC, Phair JP, Neumann AU, Ho DD, Wolinsky SM. Zhang L, et al. J Virol. 1998 Nov;72(11):9307-12. doi: 10.1128/JVI.72.11.9307-9312.1998. J Virol. 1998. PMID: 9765480 Free PMC article. - Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage.
Mörner A, Björndal A, Albert J, Kewalramani VN, Littman DR, Inoue R, Thorstensson R, Fenyö EM, Björling E. Mörner A, et al. J Virol. 1999 Mar;73(3):2343-9. doi: 10.1128/JVI.73.3.2343-2349.1999. J Virol. 1999. PMID: 9971817 Free PMC article. - Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry.
Simmons G, Wilkinson D, Reeves JD, Dittmar MT, Beddows S, Weber J, Carnegie G, Desselberger U, Gray PW, Weiss RA, Clapham PR. Simmons G, et al. J Virol. 1996 Dec;70(12):8355-60. doi: 10.1128/JVI.70.12.8355-8360.1996. J Virol. 1996. PMID: 8970955 Free PMC article. - Coreceptor usage and biological phenotypes of HIV-1 isolates.
Cilliers T, Morris L. Cilliers T, et al. Clin Chem Lab Med. 2002 Sep;40(9):911-7. doi: 10.1515/CCLM.2002.160. Clin Chem Lab Med. 2002. PMID: 12435108 Review. - Chemokine receptors and HIV.
Broder CC, Collman RG. Broder CC, et al. J Leukoc Biol. 1997 Jul;62(1):20-9. doi: 10.1002/jlb.62.1.20. J Leukoc Biol. 1997. PMID: 9225988 Review.
Cited by
- Impact of CCR2 and SDF1 polymorphisms on disease progression in HIV-infected subjects in Thailand.
Ammaranond P, Sanguansitthianan S, Phaengchomduan P, Sae-Lee C, Mardkhumchan S. Ammaranond P, et al. J Clin Lab Anal. 2013 Jan;27(1):38-44. doi: 10.1002/jcla.21559. J Clin Lab Anal. 2013. PMID: 23325742 Free PMC article. - Inhibition of HIV-1 endocytosis allows lipid mixing at the plasma membrane, but not complete fusion.
de la Vega M, Marin M, Kondo N, Miyauchi K, Kim Y, Epand RF, Epand RM, Melikyan GB. de la Vega M, et al. Retrovirology. 2011 Dec 6;8:99. doi: 10.1186/1742-4690-8-99. Retrovirology. 2011. PMID: 22145853 Free PMC article. - Evolution of the human immunodeficiency virus type 1 envelope during infection reveals molecular corollaries of specificity for coreceptor utilization and AIDS pathogenesis.
Hu QX, Barry AP, Wang ZX, Connolly SM, Peiper SC, Greenberg ML. Hu QX, et al. J Virol. 2000 Dec;74(24):11858-72. doi: 10.1128/jvi.74.24.11858-11872.2000. J Virol. 2000. PMID: 11090186 Free PMC article. - Coevolution of RANTES sensitivity and mode of CCR5 receptor use by human immunodeficiency virus type 1 of the R5 phenotype.
Karlsson I, Antonsson L, Shi Y, Oberg M, Karlsson A, Albert J, Olde B, Owman C, Jansson M, Fenyö EM. Karlsson I, et al. J Virol. 2004 Nov;78(21):11807-15. doi: 10.1128/JVI.78.21.11807-11815.2004. J Virol. 2004. PMID: 15479822 Free PMC article. - In vivo HIV-1 infection of CD45RA(+)CD4(+) T cells is established primarily by syncytium-inducing variants and correlates with the rate of CD4(+) T cell decline.
Blaak H, van't Wout AB, Brouwer M, Hooibrink B, Hovenkamp E, Schuitemaker H. Blaak H, et al. Proc Natl Acad Sci U S A. 2000 Feb 1;97(3):1269-74. doi: 10.1073/pnas.97.3.1269. Proc Natl Acad Sci U S A. 2000. PMID: 10655520 Free PMC article.
References
- J Virol. 1989 May;63(5):2118-25 - PubMed
- Nat Med. 1996 Dec;2(12):1293-300 - PubMed
- Virology. 1991 Nov;185(1):162-8 - PubMed
- J Virol. 1992 Mar;66(3):1354-60 - PubMed
- Ann Intern Med. 1993 May 1;118(9):681-8 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials